Journal of Cataract & Refractive Surgery
Volume 35, Issue 1 , Pages 26-34 , January 2009

Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain

Received 11 July 2008 ,Revised 4 September 2008 ,Accepted 5 September 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Clinical trial study numbers NCT00430092 and NCT00429923.

 Drs. Korenfeld, Silverstein, Cooke, and Crockett are consultants to Sirion Therapeutics. Dr. Vogel has a financial interest.

 Supported by Sirion Therapeutics, Tampa, Florida, USA.

 Presented at the ASCRS Symposium on Cataract, IOL and Refractive Surgery, Chicago, Illinois, USA, April 2008.

PII: S0886-3350(08)01004-3

doi: 10.1016/j.jcrs.2008.09.024

Journal of Cataract & Refractive Surgery
Volume 35, Issue 1 , Pages 26-34 , January 2009

Article Tools

* Image Usage & Resolution